accountn"May 16 (Reuters) - Mylan Inc said it launched the first generic version of Ista Pharmaceuticals Inc's twice-daily eye solution, Xibrom, to treat inflammation and pain after a cataract operation. In February, Ista discontinued shipment of Xibrom,...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to UPDATE 1-Mylan launches generic of Ista's twice-daily eye drug
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account